WO2003002117A3 - Niaciamide and derivatives in combination with aminosugar - Google Patents

Niaciamide and derivatives in combination with aminosugar Download PDF

Info

Publication number
WO2003002117A3
WO2003002117A3 PCT/DK2002/000445 DK0200445W WO03002117A3 WO 2003002117 A3 WO2003002117 A3 WO 2003002117A3 DK 0200445 W DK0200445 W DK 0200445W WO 03002117 A3 WO03002117 A3 WO 03002117A3
Authority
WO
WIPO (PCT)
Prior art keywords
complexes
aminosugar
compositions
niaciamide
derivatives
Prior art date
Application number
PCT/DK2002/000445
Other languages
French (fr)
Other versions
WO2003002117A2 (en
Inventor
Morten Sloth Weidner
Original Assignee
Astion Dev As
Morten Sloth Weidner
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astion Dev As, Morten Sloth Weidner filed Critical Astion Dev As
Priority to AU2002313458A priority Critical patent/AU2002313458A1/en
Publication of WO2003002117A2 publication Critical patent/WO2003002117A2/en
Publication of WO2003002117A3 publication Critical patent/WO2003002117A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Abstract

The present invention relates to chemical complexes consisting of a pyridine carboxy derivative and an aminosugar as well as pharmaceutical compositions and dietary supplements comprising such complexes. The invention further relates to the use of such compositions or complexes for the preparation of a medicament or a dietary supplement in the suppression of hypersensitivity and inflammatory reactions such as dermatological disorders or to a method of treating such disorders by administering such compositions and complexes to a mammal, such as a human.
PCT/DK2002/000445 2001-06-29 2002-06-28 Niaciamide and derivatives in combination with aminosugar WO2003002117A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002313458A AU2002313458A1 (en) 2001-06-29 2002-06-28 Niaciamide and derivatives in combination with aminosugar

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DKPA200101039 2001-06-29
DKPA200101039 2001-06-29
DKPA200101057 2001-07-04
DKPA200101057 2001-07-04

Publications (2)

Publication Number Publication Date
WO2003002117A2 WO2003002117A2 (en) 2003-01-09
WO2003002117A3 true WO2003002117A3 (en) 2003-03-20

Family

ID=26069045

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DK2002/000445 WO2003002117A2 (en) 2001-06-29 2002-06-28 Niaciamide and derivatives in combination with aminosugar

Country Status (2)

Country Link
AU (1) AU2002313458A1 (en)
WO (1) WO2003002117A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1232256C (en) * 2003-03-27 2005-12-21 中国人民解放军第三军医大学 Application of N-acetylglucosamine in The preparation of medicine for treating local injure or whole body syndrome due to self immune reaction
WO2005051388A1 (en) * 2003-11-21 2005-06-09 Novactyl Incorporated Compositions and methods useful for treatment of conjunctivitis
FR2876798A1 (en) 2004-10-14 2006-04-21 Univ Clermont Auvergne DIAGNOSIS AND TREATMENT OF CROHN'S DISEASE
KR20230019396A (en) * 2021-07-29 2023-02-08 프라비바이오 주식회사 Novel benzene derivative and immunosuppressive-related use thereof

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0652012A1 (en) * 1989-03-27 1995-05-10 Albert Naito Combination of sugars with animo acids and other drugs
GB2286528A (en) * 1994-02-17 1995-08-23 Robert John Woodward Dietary supplement
US5804594A (en) * 1997-01-22 1998-09-08 Murad; Howard Pharmaceutical compositions and methods for improving wrinkles and other skin conditions
US5895652A (en) * 1996-07-29 1999-04-20 Longevity Institute International Method of metabolic adjuvanation and cellular repair
WO2000007607A1 (en) * 1998-08-04 2000-02-17 Kosbab, John, V. Nutrient and therapeutic compositions for the treatment of cancer
WO2001074781A1 (en) * 2000-03-21 2001-10-11 Astion Development Aps Chemical complex comprising a substituted pyridine carboxy derivative and a glucosaminoglycan
US20020068718A1 (en) * 2000-10-03 2002-06-06 Pierce Scott W. Chondroprotective/restorative compositions and methods of use thereof

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0652012A1 (en) * 1989-03-27 1995-05-10 Albert Naito Combination of sugars with animo acids and other drugs
GB2286528A (en) * 1994-02-17 1995-08-23 Robert John Woodward Dietary supplement
US5895652A (en) * 1996-07-29 1999-04-20 Longevity Institute International Method of metabolic adjuvanation and cellular repair
US5804594A (en) * 1997-01-22 1998-09-08 Murad; Howard Pharmaceutical compositions and methods for improving wrinkles and other skin conditions
WO2000007607A1 (en) * 1998-08-04 2000-02-17 Kosbab, John, V. Nutrient and therapeutic compositions for the treatment of cancer
WO2001074781A1 (en) * 2000-03-21 2001-10-11 Astion Development Aps Chemical complex comprising a substituted pyridine carboxy derivative and a glucosaminoglycan
US20020068718A1 (en) * 2000-10-03 2002-06-06 Pierce Scott W. Chondroprotective/restorative compositions and methods of use thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
GABY A R: "NATURAL TREATMENTS FOR OSTEOARTHRITIS", ALTERNATIVE MEDICINE REVIEW, THORNE RESEARCH INC., SANDPOINT,, US, vol. 4, no. 5, 1999, pages 330 - 341, XP000992206, ISSN: 1089-5159 *
KROEGER H ET AL: "THE INFLUENCE OF NICOTINAMIDE, TRYPTOPHAN, AND METHIONINE UPON GALACTOSAMINE-INDUCED EFFECTS IN THE LIVER", ARZNEIMITTEL FORSCHUNG. DRUG RESEARCH, EDITIO CANTOR. AULENDORF, DE, vol. 31, no. 6, PART 1, 1981, pages 987 - 993, XP002949715, ISSN: 0004-4172 *

Also Published As

Publication number Publication date
AU2002313458A1 (en) 2003-03-03
WO2003002117A2 (en) 2003-01-09

Similar Documents

Publication Publication Date Title
AU2002351583A1 (en) Chitosan oligosaccharides and uses thereof
AU2903300A (en) Novel pharmaceuticals, dietary supplements and cosmetic compositions, and the use of certain mixtures for preparing medicament or a dietary supplement for thetreatment or prevention of inflammation, hypersensitivity reactions or pain
AU2004253242B2 (en) Formulations for the treatment of arhritis conditions
EP2123282A3 (en) Immunemodulating oligosaccharides
WO2001090091A8 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
WO2003011881A3 (en) Sugar derivatives of hydromorphone, dihydromorphine and dihydroisomorphine, compositions thereof and uses for treating or preventing pain
WO2003009741A3 (en) Methods for treating joint inflammation, pain, and loss of mobility
WO2006120681A3 (en) Compositions and methods for skin care
AU2728900A (en) Multi-purpose acid compositions
WO2007064968A3 (en) Stable pharmaceutical compositions of 5,10 methylenetetrahydrofolate
PT1200106E (en) COMPOSITION CONTAINING BUTYROSPERMUM PARKII EXTRACTS AND USES AS A MEDICATION OR DIETETIC SUPPLEMENT
EP1393734A4 (en) Drugs for intestinal diseases
WO2003002125A3 (en) Combination of aminosugars and cysteine or cysteine derivatives
HUP0304077A2 (en) Pharmaceutical and cosmetic compositions against skin aging
WO2001074780A8 (en) Chemical complex comprising a pyridine carboxy derivative and an h2 histamine receptor antagonist
WO2003002117A3 (en) Niaciamide and derivatives in combination with aminosugar
WO2002072035A3 (en) Novel anti-inflammatory compositions and methods of use
WO2004033484A3 (en) Use of stable glutamine derivatives to improve drug absorption
WO2004006887A3 (en) Composition and methods for the treatment of skin disorders
EP0737476A3 (en) A pharmaceutical preparation containing a 3-(2H)-furanone derivative for prevention and/or treatment of cataracts
WO2004030684A3 (en) Kavalactone product
SI1363588T1 (en) Pharmaceutical and cosmetic compositions for the protection of the skin from damages induced by sun radiations
WO2005030785A3 (en) Novel thioxylose compounds, preparation method thereof, pharmaceutical compositions containing same and use thereof in therapeutics
EP1474998B1 (en) Composition useful for weight control
EP1611895A8 (en) Use of n-acetyl-d-aminoglycosamine in treatment of organ lesions related to toxicosis of drugs or chemicals

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ CZ DE DE DK DK DM DZ EC EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
ENP Entry into the national phase

Ref document number: 2004104630

Country of ref document: RU

Kind code of ref document: A

Ref document number: 2004105928

Country of ref document: RU

Kind code of ref document: A

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP